Variable | Number of patients (ntotal = 68) |
---|---|
Initial treatment, n (%) | Â |
Artesunate | 43 (63) |
   monotherapy | 39 (57) |
   + clindamycin | 2 (3) |
   + doxycycline | 2 (3) |
Quinine | 19 (28) |
AP | 2 (3) |
AL | 2 (3) |
SP + doxycycline | 1 (2) |
Unknown oral anti-malarial | 1 (2) |
Artesunate | Â |
Median number of doses (range) | 3 (1-7) |
Median cumulative dose (range), mg | 600 (120-1320) |
Median cumulative dose/bodyweight (range), mg/kg | 7.5 (2.3-18.1) |
Oral anti-malarial drug after artesunate, n (%) | Â |
AP | 41 (60) |
AL | 20 (29) |
Doxycycline | 2 (3) |
Doxycycline + Quinine | 1 (2) |
Clindamycin + Quinine | 1 (2) |
AP + mefloquine | 1 (2) |
Primaquine | 1 (2) |
Mefloquine | 1 (2) |
Supportive care, n (%) | Â |
Erythrocytapheresis | 4 (6) |
Exchange transfusion | 13 (19) |
Blood transfusion | 9 (13) |
Platelets transfusion | 1 (2) |
Mechanical ventilation | 6 (9) |
Haemodialysis | 5 (7) |